Lifetime marijuana use and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study

BACKGROUND AND AIMS Unlike tobacco, the effect of marijuana smoke on subclinical atherosclerosis, a surrogate measure for cardiovascular disease, is not known. This study aimed to determine the association between lifetime exposure to marijuana and measures of subclinical atherosclerosis in mid-life. DESIGN, SETTING AND PARTICIPANTS We used data from the US-based Coronary Artery Risk Development in Young Adults (CARDIA) study, a cohort of black and white men and women aged 18-30 years at baseline in 1985-86, with up to seven follow-up examinations over 25 years. A total of 3498 participants in the CARDIA study were included in this study. MEASUREMENTS Cumulative years of exposure to marijuana (expressed in 'marijuana-years', with 1 marijuana-year equivalent to 365 days of use) using repeated assessments every 2-5 years for 25 years. Abdominal artery calcium (AAC) and coronary artery calcium (CAC) scores were measured by computed tomography at year 25 examination. RESULTS Among 3117 participants with AAC and CAC measurements, 2627 (84%) reported past marijuana use and 1536 (49%) past daily tobacco smoking. Compared with tobacco smokers, 46% of whom reported 10 or more pack-years of use, only 12% of marijuana users reported 5 or more marijuana-years of use and only 6% reported having used marijuana daily. We found a significant interaction between never and ever tobacco users on the association between cumulative marijuana use and AAC (P = 0.05). Among those who never smoked tobacco, cumulative marijuana-years were not associated with AAC or CAC in models adjusted for demographics, cardiovascular risk factors, licit and illicit drug exposure and depression symptoms. However, among ever tobacco smokers, marijuana exposure was associated with AAC and CAC. At 5 marijuana-years of exposure, using AAC = 0 and CAC = 0 as a reference group, the odds ratio (OR) was 1.97 [95% confidence interval (CI) = 1.21-3.21, P = 0.007] for AAC > 0/CAC = 0 and 1.83 (95% CI = 1.02-3.31, P = 0.04) for CAC > 0), regardless of AAC. Tobacco smoking was associated strongly with both AAC and CAC. CONCLUSION Marijuana use appears to be associated with subclinical atherosclerosis, but only among ever tobacco users.

[1]  T. Kawada.  Letter by Kawada Regarding Article, "Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45 000 Swedish Men". , 2017, Stroke.

[2]  M. Pletcher,et al.  Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2017, American journal of public health.

[3]  P. Allebeck,et al.  Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45 000 Swedish Men , 2017, Stroke.

[4]  N. Jacobsen,et al.  Atherosclerosis and vasomotor dysfunction in arteries of animals after exposure to combustion-derived particulate matter or nanomaterials , 2016, Critical reviews in toxicology.

[5]  M. Pletcher,et al.  Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. , 2016, JAMA internal medicine.

[6]  M. Budoff,et al.  Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study , 2016, PloS one.

[7]  Jeesun Jung,et al.  Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. , 2015, JAMA psychiatry.

[8]  S. Martins,et al.  Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity. , 2015, Drug and alcohol dependence.

[9]  R. Zane,et al.  The implications of marijuana legalization in Colorado. , 2015, JAMA.

[10]  K. Watson,et al.  Abdominal Aortic Calcium, Coronary Artery Calcium, and Cardiovascular Morbidity and Mortality in the Multi-Ethnic Study of Atherosclerosis , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[11]  M. Lapeyre-Mestre,et al.  Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders , 2014, Journal of the American Heart Association.

[12]  M. Pletcher,et al.  Early Adult to Midlife Cardiovascular Risk Factors and Cognitive Function , 2014, Circulation.

[13]  Juned Siddique,et al.  Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. , 2014, JAMA.

[14]  D. Jacobs,et al.  Subclinical atherosclerotic calcification and cognitive functioning in middle-aged adults: the CARDIA study. , 2013, Atherosclerosis.

[15]  A. Berchtold,et al.  To what extent does adding tobacco to cannabis expose young users to nicotine? , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[16]  M. Chonchol,et al.  Calcification of the abdominal aorta as an independent predictor of cardiovascular events: a meta-analysis , 2012, Heart.

[17]  J. Mehta,et al.  Cannabinoids and Atherosclerotic Coronary Heart Disease , 2012, Clinical cardiology.

[18]  M. Pencina,et al.  Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events. , 2012, The American journal of cardiology.

[19]  M. Pletcher,et al.  Association between marijuana exposure and pulmonary function over 20 years. , 2012, JAMA.

[20]  Eric J Tchetgen Tchetgen,et al.  Accounting for Bias Due to Selective Attrition: The Example of Smoking and Cognitive Decline , 2012, Epidemiology.

[21]  M. Roizen,et al.  Public health importance of triggers of myocardial infarction: a comparative risk assessment , 2012 .

[22]  M. Pletcher,et al.  Trajectories of Drug Use and Mortality Outcomes Among Adults Followed Over 18 Years , 2012, Journal of General Internal Medicine.

[23]  J. Després,et al.  Effect of rimonabant on carotid intima–media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR Trial , 2011, Heart.

[24]  A. Caspi,et al.  Effects of cannabis on lung function: a population-based cohort study , 2010, European Respiratory Journal.

[25]  MasafumiNakayama,et al.  Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages , 2009 .

[26]  E. V. van Beurden,et al.  The Mull Hypothesis: is cannabis use contributing to high tobacco use prevalence among young North Coast males? , 2008, New South Wales public health bulletin.

[27]  Deepak L. Bhatt,et al.  Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. , 2008, JAMA.

[28]  Moyses Szklo,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[29]  D. Jacobs,et al.  Passive smoke exposure trends and workplace policy in the Coronary Artery Risk Development in Young Adults (CARDIA) study (1985-2001). , 2007, Preventive medicine.

[30]  Pamela J Schreiner,et al.  Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study. , 2007, Journal of the American College of Cardiology.

[31]  F. Mach,et al.  Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice , 2005, Nature.

[32]  R. Detrano,et al.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2005, Radiology.

[33]  J. Gerberding,et al.  Actual causes of death in the United States, 2000. , 2004, JAMA.

[34]  S. Sidney.  Cardiovascular Consequences of Marijuana Use , 2002, Journal of clinical pharmacology.

[35]  J. Muller,et al.  Triggering Myocardial Infarction by Marijuana , 2001, Circulation.

[36]  J. Robins,et al.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.

[37]  G. Friedman,et al.  Marijuana use and mortality. , 1997, American journal of public health.

[38]  D. Jacobs,et al.  Physical activity in young black and white women. The CARDIA Study. , 1993, Annals of epidemiology.

[39]  G. Burke,et al.  Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. , 1992, American journal of public health.

[40]  D. Jacobs,et al.  Validity and Reliability of Short Physical Activity History: Cardia and the Minnesota Heart Health Program. , 1989, Journal of cardiopulmonary rehabilitation.

[41]  S B Hulley,et al.  CARDIA: study design, recruitment, and some characteristics of the examined subjects. , 1988, Journal of clinical epidemiology.

[42]  M. Novotny,et al.  Fractionation and capillary gas chromatographic—mass spectrometric characterization of the neutral components in marijuana and tobacco smoke condensates , 1982 .

[43]  L. Radloff.  The CES-D Scale , 1977 .